Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Recombinant human coagulation factor VIII-Fc fusion protein (Gensciences) in Hemophilia A: NCT06136507 Clinical Landscape Report 2026
28 September 2026
NCT06136507 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PEGylated Recombinant Human Coagulation Factor VIII Fc Fusion Protein (Jiangsu Gensciences) in Hemophilia A: NCT06142552 Clinical Landscape Report 2026
28 September 2026
NCT06142552 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HBI-002 in Acute Chest Syndrome: NCT06144749 Clinical Landscape Report 2026
28 September 2026
NCT06144749 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Anemia, Sickle Cell: NCT06171217 Clinical Landscape Report 2026
28 September 2026
NCT06171217 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: NCT06145373 Clinical Landscape Report 2026
28 September 2026
NCT06145373 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Abatacept in Acute Chest Syndrome: NCT06145282 Clinical Landscape Report 2026
28 September 2026
NCT06145282 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aspirin in Hemoglobin SC Disease: CTRI/2023/12/060832 Clinical Landscape Report 2026
28 September 2026
CTRI/2023/12/060832 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HIX-763 in Anemia, Sickle Cell: NCT06155500 Clinical Landscape Report 2026
28 September 2026
NCT06155500 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Etavopivat in Anemia, Sickle Cell: NCT06198712 Clinical Landscape Report 2026
28 September 2026
NCT06198712 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemarthrosis: NCT06155955 Clinical Landscape Report 2026
28 September 2026
NCT06155955 clinical landscape for Hemarthrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emicizumab in Hemophilia A: CTRI/2024/01/061593 Clinical Landscape Report 2026
28 September 2026
CTRI/2024/01/061593 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Valoctocogene roxaparvovec in Hemophilia A: NCT06224907 Clinical Landscape Report 2026
28 September 2026
NCT06224907 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.